Cargando…
Clemastine protects against sepsis-induced myocardial injury in vivo and in vitro
Sepsis-induced myocardial dysfunction (SIMD) is associated with high morbidity and mortality rates; however, it lacks targeted therapies. Modulating cardiomyocyte autophagy maintains intracellular homeostasis during SIMD. Clemastine, a histamine receptor inhibitor, promotes autophagy and other effec...
Autores principales: | Wang, Xiaowan, Xie, Di, Dai, Hui, Ye, Jiawei, Liu, Yuqi, Fei, Aihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208445/ https://www.ncbi.nlm.nih.gov/pubmed/35274595 http://dx.doi.org/10.1080/21655979.2022.2047256 |
Ejemplares similares
-
Clemastine Fumarate Protects Against Myocardial Ischemia Reperfusion Injury by Activating the TLR4/PI3K/Akt Signaling Pathway
por: Yuan, Xiaoxiao, et al.
Publicado: (2020) -
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury
por: Myatich, Ali, et al.
Publicado: (2022) -
Clemastine Fumarate Attenuates Myocardial Ischemia Reperfusion Injury Through Inhibition of Mast Cell Degranulation
por: Meng, Shuqi, et al.
Publicado: (2021) -
Clemastine Induces an Impairment in Developmental Myelination
por: Palma, Ana, et al.
Publicado: (2022) -
Insights on therapeutic potential of clemastine in neurological disorders
por: Jiang, Sufang, et al.
Publicado: (2023)